Brief: Lantheus Holdings Q4 Free Cash Flow USD 100.2 Million
Feb 22 (Reuters) - Lantheus Holdings Q4 revenue USD 354 million vs. IBES estimate USD 342.3 million. * Q4 net income USD 103.4 million
Recent news on Lantheus Holdings
See all newsStreet View: Lantheus' tumor kit setback seen as temporary, with growth catalysts still ahead
Brief: Lantheus Receives Complete Response Letter From FDA For Lnth-2501 (Ga 68 Edotreotide)
US FDA declines Lantheus’ tumor imaging kit over third-party manufacturing issues (updated)
US FDA declines to approve Lantheus’ tumor imaging kit
$7 billion could be a 'light' price tag for Lantheus, Truist analysts say